Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bridgewater

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
European Radiology|April 3, 2019
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experimentAnne Miles, Stuart A Taylor, Ruth E C Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic CancerChristopher N Hurt, Somnath Mukherjee, John Bridgewater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumorsMalcolm Ranson, Mark R Middleton, John Bridgewater, et al.
Therapeutic Advances in Medical Oncology|September 24, 2020
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experienceNalinie Joharatnam-Hogan, Daniel Hochhauser, Kai-Keen Shiu, et al.
ESMO Open|August 11, 2018
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancerStephen P Pereira, Mark Jitlal, Marian Duggan, et al.
BMC Cancer|April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trialsMairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Therapeutic Advances in Medical Oncology|November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort studyValerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
Health Technology Assessment (Winchester, England)|December 20, 2019
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studiesStuart A Taylor, Susan Mallett, Anne Miles, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
European Radiology|April 3, 2019
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experimentAnne Miles, Stuart A Taylor, Ruth E C Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic CancerChristopher N Hurt, Somnath Mukherjee, John Bridgewater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumorsMalcolm Ranson, Mark R Middleton, John Bridgewater, et al.
Therapeutic Advances in Medical Oncology|September 24, 2020
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experienceNalinie Joharatnam-Hogan, Daniel Hochhauser, Kai-Keen Shiu, et al.
ESMO Open|August 11, 2018
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancerStephen P Pereira, Mark Jitlal, Marian Duggan, et al.
BMC Cancer|April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trialsMairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Therapeutic Advances in Medical Oncology|November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort studyValerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
Health Technology Assessment (Winchester, England)|December 20, 2019
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studiesStuart A Taylor, Susan Mallett, Anne Miles, et al.
Pageof 13